Skip to main content

3 Result(s)

within Abualbishr Alshreef Remove this filter Health Economics Remove this filter

and

  1. Article

    Open Access

    Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study

    Becky Pennington, Abualbishr Alshreef, Laura Flight, Andrew Metry… in PharmacoEconomics (2021)

    Download PDF (307 KB) View Article

  2. Article

    Open Access

    Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study

    We aimed to assess the cost effectiveness of intravitreal ranibizumab (Lucentis), aflibercept (Eylea) and bevacizumab (Avastin) for the treatment of macular oedema due to central retinal vein occlusion.

    Becky Pennington, Abualbishr Alshreef, Laura Flight, Andrew Metry… in PharmacoEconomics (2021)

    Download PDF (1520 KB) View Article

  3. No Access

    Article

    Review of Economic Submissions to NICE Medical Technologies Evaluation Programme

    The economic evaluation of medical devices is increasingly used to inform decision making on adopting new or novel technologies; however, challenges are inevitable due to the unique characteristics of devices....

    Abualbishr Alshreef, Michelle Jenks… in Applied Health Economics and Health Policy (2016)